443 related articles for article (PubMed ID: 38075261)
1. Gut-brain axis: gut dysbiosis and psychiatric disorders in Alzheimer's and Parkinson's disease.
Denman CR; Park SM; Jo J
Front Neurosci; 2023; 17():1268419. PubMed ID: 38075261
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
Zheng Y; Bonfili L; Wei T; Eleuteri AM
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
[TBL] [Abstract][Full Text] [Related]
4. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.
Gubert C; Kong G; Renoir T; Hannan AJ
Neurobiol Dis; 2020 Feb; 134():104621. PubMed ID: 31628992
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
[TBL] [Abstract][Full Text] [Related]
6. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
7. Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?
Tan LY; Yeo XY; Bae HG; Lee DPS; Ho RC; Kim JE; Jo DG; Jung S
Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357070
[TBL] [Abstract][Full Text] [Related]
8. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.
Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373
[TBL] [Abstract][Full Text] [Related]
9. An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders.
Borrego-Ruiz A; Borrego JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110861. PubMed ID: 37690584
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
Liu S; Gao J; Zhu M; Liu K; Zhang HL
Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
[TBL] [Abstract][Full Text] [Related]
11. The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders.
Raval U; Harary JM; Zeng E; Pasinetti GM
Expert Rev Neurother; 2020 Jul; 20(7):673-686. PubMed ID: 32459513
[TBL] [Abstract][Full Text] [Related]
12. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
13. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota and Neurologic Diseases and Injuries.
Tyler Patterson T; Grandhi R
Adv Exp Med Biol; 2020; 1238():73-91. PubMed ID: 32323181
[TBL] [Abstract][Full Text] [Related]
15. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
Goyal D; Ali SA; Singh RK
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
[TBL] [Abstract][Full Text] [Related]
17. Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders.
Wiefels MD; Furar E; Eshraghi RS; Mittal J; Memis I; Moosa M; Mittal R; Eshraghi AA
Curr Neuropharmacol; 2024; 22(1):123-139. PubMed ID: 36200211
[TBL] [Abstract][Full Text] [Related]
18. Gut dysbiosis and age-related neurological diseases in females.
Korf JM; Ganesh BP; McCullough LD
Neurobiol Dis; 2022 Jun; 168():105695. PubMed ID: 35307514
[TBL] [Abstract][Full Text] [Related]
19. Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease.
Susmitha G; Kumar R
Neuropharmacology; 2023 May; 229():109478. PubMed ID: 36871788
[TBL] [Abstract][Full Text] [Related]
20. The Gut-Brain Axis and Its Relation to Parkinson's Disease: A Review.
Klann EM; Dissanayake U; Gurrala A; Farrer M; Shukla AW; Ramirez-Zamora A; Mai V; Vedam-Mai V
Front Aging Neurosci; 2021; 13():782082. PubMed ID: 35069178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
